Both hyperglycemia and hypoglycemia in patients at the intensive care unit (ICU) are strongly associated with increased morbidity and mortality. Accurate and timely measurements of glucose levels in this population are therefore crucial. Continuous glucose monitoring (CGM) appears promising for this purpose, but it is not yet used in the ICU due to insufficient knowledge about its reliability in critically ill patients. The aim of this study is to investigate the discrepancy between CGM and point-of-care measurements in ICU patients and whether this discrepancy is consistent across all ICU patient groups/characteristics. This study investigates whether continuous glucose monitoring can be used in the intensive care setting.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Discrepancy glucose CGM - POC
Timeframe: From enrollment until the completion of the continuous glucose monitoring (CGM) placement at 10 days.
Variation discrepancy across patient-related factors
Timeframe: From enrollment until the completion of the continuous glucose monitoring (CGM) placement at 10 days.